Cargando…
Mycophenolate mofetil for myasthenia gravis: a clear and present controversy
Mycophenolate mofetil (MMF) has been used to treat myasthenia gravis (MG) for over 10 years. MMF’s use in the MG population stems from its theoretical mechanism of action and the medical literature that supports its benefit in MG patients. Recently, two large, double-blinded, placebo-controlled, ran...
Autores principales: | Heatwole, Chad, Ciafaloni, Emma |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2646649/ https://www.ncbi.nlm.nih.gov/pubmed/19337460 |
Ejemplares similares
-
Cytomegalovirus Retinitis in a Patient on Long-term Mycophenolate Mofetil Treatment for Myasthenia Gravis
por: Patel, Shyam, et al.
Publicado: (2020) -
Mycophenolate mofetil as second line immunosuppressant in myasthenia gravis - a long-term prospective open-label study
por: Hanisch, F, et al.
Publicado: (2009) -
Controversies in Ocular Myasthenia Gravis
por: Evoli, Amelia, et al.
Publicado: (2020) -
A case report of immune checkpoint inhibitor-related steroid-refractory myocarditis and myasthenia gravis-like myositis treated with abatacept and mycophenolate mofetil
por: Jespersen, Mette Syberg, et al.
Publicado: (2021) -
Comparison of Renal Responses Between Continuous Mycophenolate Mofetil and Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium in Lupus Nephritis
por: Liao, Yu-Wan, et al.
Publicado: (2022)